Citigroup Inc. Stock
€87.31
Your prediction
Citigroup Inc. Stock
Pros and Cons of Citigroup Inc. in the next few years
Pros
Cons
Performance of Citigroup Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Citigroup Inc. | 0.170% | -0.559% | 5.050% | 36.102% | 29.049% | 92.449% | 116.090% |
| Comerica Inc. | -0.730% | 2.239% | -1.439% | 6.202% | 15.126% | 0.735% | 49.563% |
| Citizens Financial | 0.190% | 1.360% | -0.312% | 4.573% | 7.969% | 10.668% | 63.175% |
| Regions Financial Corp | -0.940% | 2.857% | -1.818% | -10.000% | -4.425% | -4.425% | 67.442% |
Comments
News
Citigroup Says This Obesity Drugmaker's Stock Is Now a Buy
Congratulations are (still) in order for pharmaceutical giants Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY). Lilly's Zepbound and Mounjaro along with Novo's Saxenda and Wegovy remain the
What Will Plug Power's Stock Price Be in 1 Year?
Plug Power (NASDAQ: PLUG) is a controversial stock. According to some of the Wall Street analysts who cover the company, shares could more than double in price over the next year. Others, however
BioAge Labs Stock Just Soared. Does It Have More Fuel to Climb Higher?
Most of 2025 has been disappointing for BioAge Labs (NASDAQ: BIOA) shareholders, but things are looking up. During the week that ended Oct. 25, shares of the obesity drug developer soared by 46.6%.


